QILU PUGET SOUND BIOTHERAPEUTICS CORP has a total of 14 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are DRAGONFLY THERAPEUTICS INC, TON LOGTENBERG and ULTRAHUMAN FOUR LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Liu Zhi | 14 |
#2 | Yan Wei | 14 |
#3 | Pentony Martin J | 6 |
#4 | Fanslow William C | 6 |
#5 | Zhonghua Hu | 5 |
#6 | Hu Zhonghua | 2 |
#7 | Peng Yufeng | 1 |
#8 | Fanslow William | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021041678A1 | Anti-cd20 antibodies, anti-cd37 antibodies, and mixtures thereof | |
WO2020180811A1 | Anti-sirp-alpha antibodies | |
AU2017356860A1 | Anti-PD1 and anti-CTLA4 antibodies | |
CA3025162A1 | Mixtures of antibodies |